Their JPM update confirms they are progressing with all three...

First 14050 Last

Share
Profile

Follow
htae39

2,623 Posts.

777

29/01/25

10:48

Post #: 77600334
Share

Originally posted by Taureanbull: ↑

NEU released the results of PH2 trial for PMS on 18/12/23 then held the follow up meeting with the FDA on about 23/9/24!

Then on 27/5/24 NEU released the results of the Pitt-Hopkins Syndrome PH2 Trial .

If the PMS timeline is a rough guide we should expect a FDA follow up meeting for Pitt Hopkins at the end of February or early March.

NEU told us months before the first FDA meeting when it was due. My question is why haven’t NEU spoken about a follow up meeting for Pitt-Hopkins. Are NEU working towards a ph3 trial such as PMS. Or have they put the progress of the program to the side for the moment.

Maybe we will hear news shortly. Or just maybe all of those meetings at JPM are forming the basis af discussion in the Boardroom, to decide on the path forward for NEU.

I do remember JP saying a while back that there was a lot of options to consider before deciding on the direction NEU would take from here.

Expand

Their JPM update confirms they are progressing with all three programs, PMS, PH, AS. AS was a surprise for me.

I suspect we will hear about it (FDA meeting for PH) after it has happened.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02904379-2A1574140

NEU Price at posting: $14.63 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

HAR

Haranga jumps +7% on Lincoln acquisition

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

First 14050 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $16.63		Change -0.070(0.42%)		Mkt cap ! $2.095B

Open	High	Low	Value	Volume
$16.68	$16.86	$16.51	$4.012M	240.7K

Buyers (Bids)

No.	Vol.	Price($)
2	982	$16.60

Sellers (Offers)

Price($)	Vol.	No.
$16.66	1000	1

View Market Depth

No.	Vol.	Price($)
2	982	16.600
1	60	16.550
5	11099	16.500
1	60	16.490
1	200	16.470

Price($)	Vol.	No.
16.660	1000	1
16.740	2114	2
16.750	982	2
16.800	703	1
16.890	175	2

Last trade - 16.10pm 30/07/2025 (20 minute delay)

NEU (ASX) Chart

Their JPM update confirms they are progressing with all three...

Neurizon inks $1.5M loan against R&D Tax Rebate

Haranga jumps +7% on Lincoln acquisition

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Their JPM update confirms they are progressing with all three...

Top Stories

Neurizon inks $1.5M loan against R&D Tax Rebate

Haranga jumps +7% on Lincoln acquisition

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News